Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, novembre 17
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Strata Critical Medical Inc
SRTA
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$5.29
-0.13
-2.31%
Ult. Agg.: Nov 17, 1:12 PM
Get Report
Panoramica
Notizie
Grafici
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Strata Critical Medical Financials
Strata Critical Medical (SRTA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Strata Critical Medical Affirms FY2026 Sales Guidance of $285.000M-$295.000M vs $290.804M Est
Strata Critical Medical (NASDAQ:SRTA) affirms FY2026 sales outlook from $285.000 million-$295.000 million to $285.000 million-$295.000 million vs $290.804 million estimate.
Benzinga Newsdesk
PRO
Strata Critical Medical Q3 EPS $(0.09) Misses $(0.01) Estimate, Sales $74.081M Beat $72.669M Estimate
Strata Critical Medical (NASDAQ:SRTA) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.01) by 800 percent. This is a 25 percent increase over losses of $(0.12) per share
Benzinga Newsdesk
PRO
Strata Critical Medical Q2 EPS $(0.12) Misses $(0.02) Estimate, Sales $72.506M Beat $67.112M Estimate
Benzinga Newsdesk
PRO
Strata Critical Medical Raises FY2026 Sales Guidance from $260.000M-$275.000M to $285.000M-$295.000M vs $275.746M Est
Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $260.000 million-$275.000 million to $285.000 million-$295.000 million vs $275.746 million estimate.
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
PRO
Strata Critical Medical Affirms FY2026 Sales Guidance of $260.000M-$275.000M vs $269.175M Est
Strata Critical Medical (NASDAQ:SRTA) affirms FY2026 sales outlook from $260.000 million-$275.000 million to $260.000 million-$275.000 million vs $269.175 million estimate.
Benzinga Newsdesk